Pharmaceuticals, Biotechnology and Life Sciences
GW Pharmaceuticals and its U.S. subsidiary Greenwich Biosciences, have conducted a study which showed the potential of cannabidiol in reducing…
Novartis on Wednesday said it has made a with deal Spark Therapeutics about the rights for voretigene neparvovec in markets…
N4 Pharma will present its Nuvec in a meeting with japanese companies in February. The UK pharmaceutical company will be…
Belgian based drugmaker Ablynx has appointed Robert Friesen, PhD, as Chief Scientific Officer (CSO), who will begin his role in…
ImmuPharma has completed a fundraise totalling £10 million (14.03million) before expenses by placing 6,944,445 new ordinary shares of 10p each…
Portola Pharmaceuticals said that it will present an abstract about results from its trial in Phase 3b/4 of its investigational…
Join ProcureCon Pharma to learn how to master Analytical and Digital Procurement in Pharma. Download agenda here: https://procureconhealthcare.wbresearch.com
Baxter International has announced the U.S. Food and Drug Administration (FDA) approval of Bivalirudin in 0.9 percent Sodium Chloride Injection…
Amgen’s Phase 3b study called Liberty, in co-development with Novartis, aimed to test Aimovig for treating migraine, has met it’s…
Alexion Pharmaceuticals has welcomed Deborah Dunsire, M.D. as the company’s Board of Directors new independent director.